Document:

Exhibit 10.4

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS AGREEMENT
(this “Agreement”), dated as of August 30, 2021, is made and entered into by and among CHW Acquisition Corporation,
a Cayman Islands exempted company (the “Company”), and the undersigned parties listed under Investors on the
signature page hereto (each, an “Investor” and collectively, the “Investors”).

 

RECITALS

 

WHEREAS, the Company
and the Investors desire to enter into this Agreement, pursuant to which the Company shall grant the Investors certain registration rights
with respect to certain securities of the Company held by them as of the date hereof or that may be held by them upon consummation of
a Business Combination (defined below);

 

NOW, THEREFORE,
in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

ARTICLE
I DEFINITIONS

 

Section
1.01             
The terms defined in this ARTICLE I shall, for all purposes of this Agreement, have the respective meanings set
forth below:

 

“Adverse Disclosure”
shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Chief Executive
Officer or principal financial officer of the Company, after consultation with counsel to the Company, (i) would be required to be made
in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any Prospectus
and any preliminary Prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required
to be made at such time if the Registration Statement were not being filed, and (iii) the Company has a bona fide business purpose for
not making such information public.

 

“Agreement”
shall have the meaning given in the Preamble.

 

“Board”
shall mean the Board of Directors of the Company.

 

“Business Combination”
shall mean any merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one
or more businesses, involving the Company.

 

“Commission”
shall mean the Securities and Exchange Commission.

 

“Company”
shall have the meaning given in the Preamble.

 

“Demand Registration”
shall have the meaning given in Section 2.01(a).

 

“Demanding Investor”
shall have the meaning given in Section 2.01(a).

 

“Exchange Act”
shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

 

“Form S-1”
shall have the meaning given in Section 2.01(a).

 

“Form S-3”
shall have the meaning given in Section 2.03.

 

    - 1 -

     

    

 

“Founder Shares”
shall mean the 3,162,500 Ordinary Shares that Sponsor purchased from the Company pursuant to the Founder Shares Purchase Agreement (up
to 412,500 of which are subject to forfeiture depending on the extent to which the Underwriters’ over-allotment option is exercised)
and shall be deemed to include the Ordinary Shares issuable upon conversion thereof.

 

“Founder Shares
Lock-up Period” shall mean, with respect to the Founder Shares, the period ending (A) with respect to 50% of the Founder
Shares, the earlier of six months after the completion of the Company's initial Business Combination or the date on which the closing
price of our ordinary shares exceeds $12.50 per share (as adjusted for share splits, share capitalizations, reorganizations and recapitalizations)
for any 20 trading days within any 30-trading day period commencing after the initial Business Combination, and (B) with respect to the
remaining 50% of the Founder Shares, six months after the date of the initial Business Combination or earlier if approved by the shareholders
of the Company, and in either case, if, subsequent to the initial Business Combination, the Company consummates a liquidation, merger,
share exchange or other similar transaction that results in all of our shareholders having the right to exchange their shares for cash,
securities or other property.

 

“Founder Shares
Purchase Agreement” shall mean that certain Securities Subscription Agreement by and between the Sponsor and Company, dated
as of January 18, 2021.

 

“Insider Letter”
shall mean that certain letter agreement, dated as of August 30, 2021, by and among the Company, the Sponsor and each of the Company’s
officers, directors and director nominees.

 

“Investors”
shall have the meaning given in the Preamble.

 

“Maximum Number
of Securities” shall have the meaning given in Section 2.01(d).

 

“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus in the light of the circumstances under which
they were made not misleading.

 

“Ordinary Shares”
shall mean the ordinary shares, par value $0.0001 per share, of the Company.

 

“Permitted Transferees”
shall mean a person or entity to whom an Investor of Registrable Securities is permitted to transfer such Registrable Securities prior
to the expiration of the Founder Shares Lock-up Period or Private Placement Lock-up Period, as the case may be, under the Insider Letter,
this Agreement, and any other applicable agreement between such Investor and the Company, and to any transferee thereafter.

 

“Piggyback Registration”
shall have the meaning given in Section 2.01(a).

 

“Private Placement
Lock-up Period” shall mean, with respect to Private Placement Warrants that are held by the initial purchasers of such Private
Placement Warrants or their Permitted Transferees, and any of the Ordinary Shares or Warrants underlying the Private Placement Warrants
and that are held by the initial purchasers of the Private Placement Units or their Permitted Transferees, the period ending 30 days after
the completion of the Company’s initial Business Combination.

 

“Private Placement
Warrants” shall mean the aggregate 4,000,000 (or up to 4,262,500, depending on the extent to which the underwriters’
over-allotment option is exercised) Warrants to be purchased by the Sponsor and/or its designees pursuant to those certain Private Placement
Warrants Purchase Agreements between the Company and each of the Sponsor, each dated August 30, 2021.

 

“Pro Rata”
shall have the meaning given in subsection Section 2.01(d).

 

“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

 

    - 2 -

     

    

 

“Registrable Security”
shall mean (a) the Founder Shares and the Ordinary Shares issued or issuable upon the conversion of any Founder Shares, (b) the Private
Placement Warrants (c) the Working Capital Warrants (and the underlying securities) of the Company issuable upon conversion of any working
capital loans in an amount up to $1,500,000 made to the Company by an Investor, if any, and (d) any other equity security of the Company
issued or issuable with respect to any such Ordinary Shares by way of a share dividend, share subdivision, share consolidation, share
capitalization or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however,
that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (i) a Registration Statement
with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold,
transferred, disposed of or exchanged in accordance with such Registration Statement; (ii) such securities shall have been otherwise transferred,
new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent
public distribution of such securities shall not require registration under the Securities Act; (iii) such securities shall have ceased
to be outstanding; (iv) such securities may be sold without Registration pursuant to Rule 144 promulgated under the Securities Act (or
any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations); or (v) such securities
have been sold to, or through, a broker, dealer or Underwriter in a public distribution or other public securities transaction.

 

“Registration”
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

 

“Registration
Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

 

(a)                
all Registration and filing fees (including fees with respect to filings required to be made with the Financial Industry
Regulatory Authority, Inc.) and any securities exchange on which the Ordinary Shares are then listed;

 

(b)               
fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel
for the Underwriters in connection with blue sky qualifications of Registrable Securities);

 

(c)                
printing, messenger, telephone and delivery expenses;

 

(d)               
reasonable fees and disbursements of counsel for the Company;

 

(e)                
reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically
in connection with such Registration; and

 

(f)                 
reasonable fees and expenses of one legal counsel selected by the majority-in-interest of the Demanding Investors initiating
a Demand Registration to be registered for offer and sale in the applicable Registration.

 

“Registration
Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this
Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements
to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

“Requesting Investor”
shall have the meaning given in Section 2.01(a).

 

“Securities Act”
shall mean the Securities Act of 1933, as amended from time to time.

 

“Sponsor”
shall mean CHW Acquisition Sponsor LLC, a Delaware limited liability company.

 

    - 3 -

     

    

 

“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer’s market-making activities.

 

“Underwritten
Registration” or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold
to an Underwriter in a firm commitment underwriting for distribution to the public.

 

“Units”
means the units of the Company, each comprised of one Ordinary Share and one Warrant.

 

“Warrants”
mean the warrants of the Company redeemable to purchase one Ordinary Share.

 

“Working Capital
Units” shall mean any Units held by Investors, officers, or directors of the Company or their respective affiliates, which
may be issued in payment of working capital loans made to the Company.

 

ARTICLE
II REGISTRATIONS

 

Section
2.01             
Demand Registration.

 

(a)                
Request for Registration. Subject to the provisions of Section 2.01(d) and Section 2.04 hereof, at any time
and from time to time on or after the date the Company consummates the Business Combination, the Investors of at least a majority in interest
of the then-outstanding number of Registrable Securities (the “Demanding Investors”) may make a written demand
for Registration under the Securities Act of all or part of their Registrable Securities, which written demand shall describe the amount
and type of securities to be included in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand
Registration”). The Company shall, within 10 days of the Company’s receipt of the Demand Registration, notify, in
writing, all other Investors of Registrable Securities of such demand, and each Investor of Registrable Securities who thereafter wishes
to include all or a portion of such Investor’s Registrable Securities in a Registration pursuant to a Demand Registration (each
such Investor that includes all or a portion of such Investor’s Registrable Securities in such Registration, a “Requesting
Investor”) shall so notify the Company, in writing, within five days after the receipt by the Investor of the notice from
the Company. Upon receipt by the Company of any such written notification from a Requesting Investor(s) to the Company, such Requesting
Investor(s) shall be entitled to have their Registrable Securities included in a Registration pursuant to a Demand Registration and the
Company shall effect, as soon thereafter as practicable, but not more than 45 days immediately after the Company’s receipt of the
Demand Registration, the Registration of all Registrable Securities requested by the Demanding Investors and Requesting Investors pursuant
to such Demand Registration. Under no circumstances shall the Company be obligated to effect more than an aggregate of three Registrations
pursuant to a Demand Registration under this Section 2.01(a) with respect to any or all Registrable Securities; provided, however,
that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form Registration Statement that may
be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested
by the Requesting Investors to be registered on behalf of the Requesting Investors in such Form S-1 Registration have been sold, in accordance
with Section 3.01 of this Agreement.

 

(b)               
Effective Registration. Notwithstanding the provisions of Section 2.01(a) above or any other part of this
Agreement, a Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement
filed with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission
and (ii) the Company has complied with all of its obligations under this Agreement with respect thereto; provided, further,
that if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant
to a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or
any other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective,
unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) a majority-in-interest of
the Demanding Investors initiating such Demand Registration thereafter affirmatively elect to continue with such Registration and accordingly
notify the Company in writing, but in no event later than five days, of such election; and provided, further, that the Company shall not
be obligated or required to file another Registration Statement until the Registration Statement that has been previously filed with respect
to a Registration pursuant to a Demand Registration becomes effective or is subsequently terminated.

 

    - 4 -

     

    

 

(c)                
 Underwritten Offering. Subject to the provisions of Section 2.01(d) and Section 2.04 hereof, if a
majority-in-interest of the Demanding Investors so advise the Company as part of their Demand Registration that the offering of the Registrable
Securities pursuant to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Investor
or Requesting Investor (if any) to include its Registrable Securities in such Registration shall be conditioned upon such Investor’s
participation in such Underwritten Offering and the inclusion of such Investor’s Registrable Securities in such Underwritten Offering
to the extent provided herein. All such Investors proposing to distribute their Registrable Securities through an Underwritten Offering
under this Section 2.01(c) shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such
Underwritten Offering by the majority-in-interest of the Demanding Investors initiating the Demand Registration.

 

(d)               
Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant
to a Demand Registration, in good faith, advises the Company, the Demanding Investors and the Requesting Investors (if any) in writing
that the dollar amount or number of Registrable Securities that the Demanding Investors and the Requesting Investors (if any) desire to
sell, taken together with all other Ordinary Shares or other equity securities that the Company desires to sell and the Ordinary Shares,
if any, as to which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by
any other shareholders who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in
the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability
of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum
Number of Securities”), then the Company shall include in such Underwritten Offering, as follows: (i) first, the Registrable
Securities of the Demanding Investors and the Requesting Investors (if any) (pro rata based on the respective number of Registrable Securities
that each Demanding Investor and Requesting Investor (if any) has requested be included in such Underwritten Registration and the aggregate
number of Registrable Securities that the Demanding Investors and Requesting Investors have requested be included in such Underwritten
Registration (such proportion is referred to herein as “Pro Rata”)) that can be sold without exceeding the Maximum
Number of Securities; (ii) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause
(i), the Registrable Securities of Investors (Pro Rata, based on the respective number of Registrable Securities that each Investor has
so requested) exercising their rights to register their Registrable Securities pursuant to Section 2.02(a) hereof, without exceeding
the Maximum Number of Securities; and (iii) third, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (i) and (ii), the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without
exceeding the Maximum Number of Securities; and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached
under the foregoing clauses (i), (ii) and (iii), the Ordinary Shares or other equity securities of other persons or entities that the
Company is obligated to register in a Registration pursuant to separate written contractual arrangements with such persons and that can
be sold without exceeding the Maximum Number of Securities.

 

(e)                
Demand Registration Withdrawal. A majority-in-interest of the Demanding Investors initiating a Demand Registration
or a majority-in-interest of the Requesting Investors (if any), pursuant to a Registration under Section 2.01(a) shall have the
right to withdraw from a Registration pursuant to such Demand Registration for any or no reason whatsoever upon written notification to
the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration prior to the effectiveness
of the Registration Statement filed with the Commission with respect to the Registration of their Registrable Securities pursuant to such
Demand Registration. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration
Expenses incurred in connection with a Registration pursuant to a Demand Registration prior to its withdrawal under this Section 2.01(e).

 

    - 5 -

     

    

 

Section
2.02             
Piggyback Registration.

 

(a)                 Piggyback
Rights. If, at any time on or after the date the Company consummates a Business Combination, the Company proposes to file a
Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations
exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of shareholders of
the Company (or by the Company and by the shareholders of the Company including, without limitation, pursuant to Section 2.01
hereof), other than a Registration Statement (i) filed in connection with any employee share option or other benefit plan, (ii) for
an exchange offer or offering of securities solely to the Company’s existing shareholders, (iii) for an offering of debt that
is convertible into equity securities of the Company or (iv) for a dividend reinvestment plan, then the Company shall give written
notice of such proposed filing to all of the Investors of Registrable Securities as soon as practicable but not less than 10 days
before the anticipated filing date of such Registration Statement, which notice shall (A) describe the amount and type of securities
to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or
Underwriters, if any, in such offering, and (B) offer to all of the Investors of Registrable Securities the opportunity to register
the sale of such number of Registrable Securities as such Investors may request in writing within five days after receipt of such
written notice (such Registration a “Piggyback Registration”). The Company shall, in good faith, cause
such Registrable Securities to be included in such Piggyback Registration and shall use its best efforts to cause the managing
Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Investors
pursuant to this Section 2.02(a) to be included in a Piggyback Registration on the same terms and conditions as any similar
securities of the Company included in such Registration and to permit the sale or other disposition of such Registrable Securities
in accordance with the intended method(s) of distribution thereof. All such Investors proposing to distribute their Registrable
Securities through an Underwritten Offering under this Section 2.02(a) shall enter into an underwriting agreement in
customary form with the Underwriter(s) selected for such Underwritten Offering by the Company.

 

(b)               
Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration
that is to be a Piggyback Registration, in good faith, advises the Company and the Investors of Registrable Securities participating in
the Piggyback Registration in writing that the dollar amount or number of the Ordinary Shares that the Company desires to sell, taken
together with (x) the Ordinary Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements
with persons or entities other than the Investors of Registrable Securities hereunder (y) the Registrable Securities as to which Registration
has been requested pursuant to Section 2.02 hereof, and (z) the Ordinary Shares, if any, as to which Registration has been requested
pursuant to separate written contractual piggy-back registration rights of other shareholders of the Company, exceeds the Maximum Number
of Securities, then:

 

(i)                 
If the Registration is undertaken for the Company’s account, the Company shall include in any such Registration (A)
first, the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum
Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause
(A), the Registrable Securities of Investors exercising their rights to register their Registrable Securities pursuant to Section 2.02(a)
hereof, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum
Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares, if any, as to which Registration
has been requested pursuant to written contractual piggy-back registration rights of other shareholders of the Company, which can be sold
without exceeding the Maximum Number of Securities; or

 

(ii)                If
the Registration is pursuant to a request by persons or entities other than the Investors of Registrable Securities, then the
Company shall include in any such Registration (A) first, the Ordinary Shares or other equity securities, if any, of such requesting
persons or entities, other than the Investors of Registrable Securities, which can be sold without exceeding the Maximum Number of
Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the
Registrable Securities of Investors exercising their rights to register their Registrable Securities pursuant to Section
2.02(a), pro rata based on the number of Registrable Securities that each Investor has requested be included in such
Underwritten Registration and the aggregate number of Registrable Securities that the Investors have requested to be included in
such Underwritten Registration, which can be sold without exceeding the Maximum Number of Securities; (C) third, to the extent that
the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares or other equity
securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the Ordinary
Shares or other equity securities for the account of other persons or entities that the Company is obligated to register pursuant to
separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of
Securities.

 

    - 6 -

     

    

 

(c)                
Piggyback Registration Withdrawal. Any Investor of Registrable Securities shall have the right to withdraw from a
Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if
any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement
filed with the Commission with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as
the result of a request for withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement
filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement.
Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in
connection with the Piggyback Registration prior to its withdrawal under this Section 2.02(c).

 

(d)               
Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section
2.02 hereof shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.01 hereof.

 

Section
2.03             
Registrations on Form S-3. The Investors of Registrable Securities may at any time, and from time to time, request
in writing that the Company, pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission),
register the resale of any or all of their Registrable Securities on Form S-3 or any similar short form Registration Statement that may
be available at such time (“Form S-3”); provided, however, that the Company shall not be obligated to effect
such request through an Underwritten Offering. Within five days of the Company’s receipt of a written request from an Investor or
Investors of Registrable Securities for a Registration on Form S-3, the Company shall promptly give written notice of the proposed Registration
on Form S-3 to all other Investors of Registrable Securities, and each Investor of Registrable Securities who thereafter wishes to include
all or a portion of such Investor’s Registrable Securities in such Registration on Form S-3 shall so notify the Company, in writing,
within 10 days after the receipt by the Investor of the notice from the Company. As soon as practicable thereafter, but not more than
12 days after the Company’s initial receipt of such written request for a Registration on Form S-3, the Company shall register all
or such portion of such Investor’s Registrable Securities as are specified in such written request, together with all or such portion
of Registrable Securities of any other Investor or Investors joining in such request as are specified in the written notification given
by such Investor or Investors; provided, however, that the Company shall not be obligated to effect any such Registration
pursuant to Section 2.03 hereof if (i) a Form S-3 is not available for such offering; or (ii) the Investors of Registrable Securities,
together with the Investors of any other equity securities of the Company entitled to inclusion in such Registration, propose to sell
the Registrable Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.

 

Section
2.04             
Restrictions on Registration Rights. If: (a) during the period starting with the date 60 days prior to the Company’s
good faith estimate of the date of the filing of, and ending on a date 120 days after the effective date of, a Company initiated Registration
and provided that the Company has delivered written notice to the Investors prior to receipt of a Demand Registration pursuant to Section
2.01(a) and it continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement
to become effective; (b) the Investors have requested an Underwritten Registration and the Company and the Investors are unable to obtain
the commitment of Underwriters to firmly underwrite the offer; or (c) in the good faith judgment of the Board such Registration would
be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer the filing of such Registration
Statement at such time, then in each case the Company shall furnish to such Investors a certificate signed by the Chairman of the Board
stating that in the good faith judgment of the Board it would be seriously detrimental to the Company for such Registration Statement
to be filed in the near future and that it is therefore essential to defer the filing of such Registration Statement. In such event, the
Company shall have the right to defer such filing for a period of not more than 30 days.

 

ARTICLE
III COMPANY PROCEDURES

 

Section
3.01              General
Procedures. If at any time on or after the date the Company consummates a Business Combination the Company is required to effect
the Registration of Registrable Securities, the Company shall use its best efforts to effect such Registration to permit the sale of
such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, as
expeditiously as possible:

 

    - 7 -

     

    

 

(a)                
prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities
and use its reasonable best efforts to cause such Registration Statement to become effective and remain effective until all Registrable
Securities covered by such Registration Statement have been sold;

 

(b)               
prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such
supplements to the Prospectus, as may be requested by the Investors or any Underwriter of Registrable Securities or as may be required
by the rules, regulations or instructions applicable to the Registration form used by the Company or by the Securities Act or rules and
regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement
are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;

 

(c)                
prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to
the Underwriters, if any, and the Investors of Registrable Securities included in such Registration, and such Investors’ legal counsel,
copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case
including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement
(including each preliminary Prospectus), and such other documents as the Underwriters and the Investors of Registrable Securities included
in such Registration or the legal counsel for any such Investors may request in order to facilitate the disposition of the Registrable
Securities owned by such Investors;

 

(d)               
prior to any public offering of Registrable Securities, use its best efforts to (i) register or qualify the Registrable
Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United
States as the Investors of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution)
may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered
with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and
do any and all other acts and things that may be necessary or advisable to enable the Investors of Registrable Securities included in
such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however,
that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required
to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it
is not then otherwise so subject;

 

(e)                
cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar
securities issued by the Company are then listed;

 

(f)                 
provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than
the effective date of such Registration Statement;

 

(g)               
advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of
the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening
of any proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain
its withdrawal if such stop order should be issued;

 

(h)               
at least five days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such
Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus,
furnish a copy thereof to each seller of such Registrable Securities or its counsel;

 

    - 8 -

     

    

 

(i)                 
 notify the Investors at any time when a Prospectus relating to such Registration Statement is required to be delivered
under the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as
then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.04 hereof;

 

(j)                 
permit a representative of the Investors (such representative to be selected by a majority of the participating Investors),
the Underwriters, if any, and any attorney or accountant retained by such Investors, or Underwriter to participate, at each such person’s
own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply
all information reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration;
provided, however, that such representative, or Underwriters enter into a confidentiality agreement, in form and substance
reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

 

(k)               
obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event
of an Underwritten Registration which the participating Investors may rely on, in customary form and covering such matters of the type
customarily covered by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory
to a majority-in-interest of the participating Investors;

 

(l)                 
on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such
date, of counsel representing the Company for the purposes of such Registration, addressed to the Investors, the placement agent or sales
agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion
is being given as the Investors, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in
such opinions and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Investors;

 

(m)              
in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual
and customary form, with the managing Underwriter of such offering;

 

(n)               
make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of
at least 12 months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration
Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule
promulgated thereafter by the Commission);

 

(o)               
if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000,
use its reasonable efforts to make available senior executives of the Company to participate in customary “road show” presentations
that may be reasonably requested by the Underwriter in any Underwritten Offering; and

 

(p)               
otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the
Investors, in connection with such Registration.

 

Section
3.02             
Registration Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged
by the Investors that the Investors shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as
Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition
of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing the Investors.

 

Section
3.03             
Requirements for Participation in Underwritten Offerings. No person may participate in any Underwritten Offering
for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (a) agrees to sell
such person’s securities on the basis provided in any underwriting arrangements approved by the Company and (b) completes and executes
all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents
as may be reasonably required under the terms of such underwriting arrangements.

 

    - 9 -

     

    

 

Section
3.04             
Suspension of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or
Prospectus contains a Misstatement, each of the Investors shall forthwith discontinue disposition of Registrable Securities until it
has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby
covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised
in writing by the Company that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration
Statement in respect of any Registration at any time would require the Company to make an Adverse Disclosure or would require the inclusion
in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control,
the Company may, upon giving prompt written notice of such action to the Investors, delay the filing or initial effectiveness of, or
suspend use of, such Registration Statement for the shortest period of time, but in no event more than 30 days, determined in good faith
by the Company to be necessary for such purpose. In the event the Company exercises its rights under the preceding sentence, the Investors
agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration
in connection with any sale or offer to sell Registrable Securities. The Company shall immediately notify the Investors of the expiration
of any period during which it exercised its rights under this Section 3.04.

 

Section
3.05             
Reporting Obligations. As long as any Investor shall own Registrable Securities, the Company, at all times while
it shall be a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within
the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or
15(d) of the Exchange Act and to promptly furnish the Investors with true and complete copies of all such filings. The Company
further covenants that it shall take such further action as any Investor may reasonably request, all to the extent required from time
to time to enable such Investor to sell Ordinary Shares held by such Investor without Registration under the Securities Act within the
limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by
the Commission), including providing any legal opinions. Upon the request of any Investor, the Company shall deliver to such Investor
a written certification of a duly authorized officer as to whether it has complied with such requirements.

 

ARTICLE
IV INDEMNIFICATION AND CONTRIBUTION

 

Section
4.01             
Indemnification by the Company. The Company agrees to indemnify, to the extent permitted by law, each Investor
of Registrable Securities, its officers and directors and each person who controls such Investor (within the meaning of the Securities
Act) against all losses, claims, damages, liabilities and expenses (including attorneys’ fees) caused by any untrue or alleged untrue
statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement
thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
not misleading, except insofar as the same are caused by or contained in any information furnished in writing to the Company by such Investor
expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors and each person who controls such
Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification
of the Investor.

 

Section
4.02              Indemnification
by Investors. In connection with any Registration Statement in which an Investor of Registrable Securities is participating,
such Investor shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in
connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify the Company, its
directors and officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any
losses, claims, damages, liabilities and expenses (including without limitation reasonable attorneys’ fees) resulting from any
untrue statement of material fact contained in the Registration Statement, Prospectus or preliminary Prospectus or any amendment
thereof or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the statements
therein not misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit
so furnished in writing by such Investor expressly for use therein; provided, however, that the obligation to
indemnify shall be several, not joint and several, among such Investors of Registrable Securities, and the liability of each such
Investor of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Investor from the sale
of Registrable Securities pursuant to such Registration Statement. The Investors of Registrable Securities shall indemnify the
Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the Securities Act) to
the same extent as provided in the foregoing with respect to indemnification of the Company.

 

    - 10 -

     

    

 

Section
4.03             
Indemnification Procedures. Any person entitled to indemnification herein shall (a) give prompt written notice
to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice
shall not impair any person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying
party) and (b) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying
parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any
settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party
who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than
one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any
indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect
to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter
into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party
pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant
or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

Section
4.04             
Effect of Investigation. The indemnification provided for under this Agreement shall remain in full force and
effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of
such indemnified party and shall survive the transfer of securities. The Company and each Investor holding Registrable Securities participating
in an offering also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party
in the event the Company’s or such Investor’s indemnification is unavailable for any reason.

 

Section
4.05             
Contribution. If the indemnification provided under Section 4.01 hereof from the indemnifying party is
unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses
referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or
payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate
to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations.
The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact, was made by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s
and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided,
however, that the liability of any Investor under this Section 4.05 shall be limited to the amount of the net proceeds
received by such Investor in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses
or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in Section 4.01, Section
4.02 and Section 4.03 above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with
any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.05
were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations
referred to in this Section 4.05. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution pursuant to this Section 4.05 from any person who was not guilty of such fraudulent
misrepresentation.

 

    - 11 -

     

    

 

ARTICLE
V 

MISCELLANEOUS

 

Section
5.01              Notices.
Any notice or communication under this Agreement must be in writing and given by (a) deposit in the United States mail, addressed to
the party to be notified, postage prepaid and registered or certified with return receipt requested, (b) delivery in person or by
courier service providing evidence of delivery, or (c) transmission by hand delivery, electronic mail, telecopy, telegram or
facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed
sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which
it is mailed and, in the case of notices delivered by courier service, hand delivery, electronic mail, telecopy, telegram or
facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such
time as delivery is refused by the addressee upon presentation. Any notice or communication under this Agreement must be addressed,
if to the Company, to: 2 Manhattanville Road, Suite 403., Purchase, NY 10577, and, if to any Investor, at such Investor’s
address or contact information as set forth in the Company’s books and records. Any party may change its address for notice at
any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective
thirty (30) days after delivery of such notice as provided in this Section 5.01.

 

Section
5.02             
Assignment; No Third Party Beneficiaries.

 

(a)                
This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company
in whole or in part.

 

(b)               
Prior to the expiration of the Founder Shares Lock-up Period or the Private Placement Lock-up Period, as the case may be,
no Investor may assign or delegate such Investor’s rights, duties or obligations under this Agreement, in whole or in part, except
in connection with a transfer of Registrable Securities by such Investor to a Permitted Transferee but only if such Permitted Transferee
agrees to become bound by the transfer restrictions set forth in this Agreement. After the expiration of the Founder Shares Lock-up Period
or the Private Placement Lock-up Period, as the case may be, the Investor may assign or delegate such Investor’s rights, duties
or obligations under this Agreement, in whole or in part, to any transferee.

 

(c)                
This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and
its successors and the permitted assigns of the Investors, which shall include Permitted Transferees.

 

(d)               
This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly
set forth in this Agreement and Section 5.02 hereof.

 

(e)                
No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or
obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section
5.01 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms
and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer
or assignment made other than as provided in this Section 5.02 shall be null and void.

 

Section
5.03             
Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts),
each of which shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need
be produced.

 

Section
5.04             
Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO,
THE PARTIES EXPRESSLY AGREE THAT (A) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED
TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW
PROVISIONS OF SUCH JURISDICTION AND (B) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT
IN NEW YORK COUNTY IN THE STATE OF NEW YORK.

 

Section
5.05              Amendments
and Modifications. Upon the written consent of the Company and the Investors of at least a majority in interest of the
Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this
Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that
notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Investor, solely in its capacity as
a holder of the shares of the Company, in a manner that is materially different from the other Investors (in such capacity) shall
require the consent of the Investor so affected. No course of dealing between any Investor or the Company and any other party hereto
or any failure or delay on the part of an Investor or the Company in exercising any rights or remedies under this Agreement shall
operate as a waiver of any rights or remedies of any Investor or the Company. No single or partial exercise of any rights or
remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies
hereunder or thereunder by such party.

 

    - 12 -

     

    

 

Section
5.06             
Other Registration Rights. The Company represents and warrants that no person, other than an Investor of Registrable
Securities, has any right to require the Company to register any securities of the Company for sale or to include such securities of the
Company in any Registration filed by the Company for the sale of securities for its own account or for the account of any other person.
Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with
similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of
this Agreement shall prevail.

 

Section
5.07             
Term. This Agreement shall terminate upon the earlier of (a) the tenth anniversary of the date of this Agreement
or (b) the date as of which (i) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event
prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated
thereafter by the Commission)) or (ii) the Investors of all Registrable Securities are permitted to sell the Registrable Securities under
Rule 144 (or any similar provision) under the Securities Act without limitation on the amount of securities sold or the manner of sale.
The provisions of Section 3.05 and ARTICLE IV shall survive any termination.

 

[SIGNATURE PAGES FOLLOW]

 

    - 13 -

     

    

 

IN WITNESS WHEREOF, the undersigned
have caused this Agreement to be executed as of the date first written above.

 

	 	COMPANY:
	 	 
	 	CHW ACQUISITION CORPORATION
	 	a Cayman Islands exempted company
	 	 
	 	By:  	/s/ Jonah Raskas
	 	 	Name:  	Jonah Raskas
	 	 	Title:  	Co-Chief Executive Officer and Director
	 	 	 	 
	 	INVESTORS:
	 	 
	 	CHW ACQUISITION SPONSOR LLC
	 	By:	CHW Acquisition Founders LLC
	 	Its:	Sole Managing Member
	 	By:	MJG Partners LLC
	 	Its:	Sole Managing Member
	 	 	 
	 	By:  	/s/ Mark Grundman
	 	 	Name:	Mark Grundman
	 	 	Title:	Manager
	 	 	 	 
	 	ANCHOR INVESTORS:
	 	 
	 	By:  	 
	 	 	Name	 
	 	 	Title:	 
	 	 	 	 
	 	By:  	 
	 	 	Name	 
	 	 	Title:Exhibit 10.5

 

INDEMNITY AGREEMENT

 

THIS INDEMNITY
AGREEMENT (this “Agreement”) is made on August 30, 2021.

 

Between:

 

	 	(1)	CHW
    Acquisition Corporation, a Cayman Islands exempted company with its registered office at
    Maples Corporate Services (Cayman) Limited, PO Box 309, Ugland house, Grand Cayman KY1-1104, Cayman Islands (the “Company”);
    and

  

	 	(2)	_____________________
    (“Indemnitee”).

 

Whereas:

 

	(A)	Highly
    competent persons have become more reluctant to serve publicly-held companies as directors, officers or in other capacities unless
    they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions
    against them arising out of their service to and activities on behalf of such companies;

 

	(B)	The board
    of directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals,
    the Company will use commercially reasonable efforts to maintain on an ongoing basis, at its sole expense, liability insurance to
    protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has
    been a customary and widespread practice among publicly traded companies and other business enterprises, the Company believes that,
    given current market conditions and trends, such insurance may be available to it in the future only at higher premiums and with
    more exclusions. At the same time, directors, officers and other persons in service to companies or business enterprises are being
    increasingly subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would
    have been brought only against the Company or business enterprise itself. The amended and restated memorandum and articles of association
    of the Company (the “Articles”) provide for the indemnification of the officers and directors of the Company.
    Indemnitee may also be entitled to indemnification pursuant to applicable Cayman Islands law. The Articles expressly provide that
    the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between
    the Company and members of the Board, officers and other persons with respect to indemnification, hold harmless, exoneration, advancement
    and reimbursement rights;

 

	(C)	The uncertainties
    relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

 

	(D)	The Board
    has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the
    Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty of such
    protection in the future;

 

	(E)	It is
    reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to
    advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue
    to serve the Company free from undue concern that they will not be so protected against liabilities;

 

	(F)	This Agreement
    is a supplement to and in furtherance of the Articles and any resolutions adopted pursuant thereto, and shall not be deemed a substitute
    therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

    	 	 	 

     

    

 

	(G)	Indemnitee
    may not be willing to serve as an officer or director, advisor or in another capacity without adequate protection, and the Company
    desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service
    for or on behalf of the Company on the condition that he be so indemnified; and

 

NOW, THEREFORE, in consideration of the premises and the covenants
contained herein and subject to the provisions of the letter agreement dated as of _______, 2021 between the Company and Indemnitee pursuant
to the Underwriting Agreement between the Company and the Underwriters in connection with the Company’s initial public offering,
the Company and Indemnitee do hereby covenant and agree as follows:

 

TERMS AND CONDITIONS

 

	1	SERVICES
    TO THE COMPANY

Indemnitee will serve or continue to serve as an officer,
director, advisor, key employee or in any other capacity of the Company, as applicable, for so long as Indemnitee is duly elected, appointed
or retained or until Indemnitee tenders his resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement
shall continue in full force and effect after Indemnitee has ceased to serve as a director, officer, advisor, key employee or in any
other capacity of the Company, as provided in Section 17. This Agreement, however, shall not impose any obligation on Indemnitee or the
Company to continue Indemnitee’s service to the Company beyond any period otherwise required by law or by other agreements or commitments
of the parties, if any.

 

	2	DEFINITIONS

As used in this Agreement:

 

	2.1	References
    to “agent” shall mean any person who is or was a director, officer or employee of the Company or a subsidiary
    of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity
    as a director, officer, employee, advisor, fiduciary or other official of another company, corporation, partnership, limited liability
    company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the
    Company or a subsidiary of the Company.

  

	2.2	The
    terms “Beneficial Owner” and “Beneficial Ownership” shall have the meanings set forth in Rule
    13d-3 promulgated under the Exchange Act (as defined below) as in effect on the date hereof.

  

	2.3	“Cayman
    Court” shall mean the Grand Court of the Cayman Islands.

 

	2.4	A “Change
    in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following
    events:

 

	 	(a)	Acquisition
    of Shares by Third Party. Other than an affiliate of CHW Acquisition Sponsor LLC, any Person
    (as defined below) is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing fifteen
    percent (15%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote generally
    in the election of directors, unless (1) the change in the relative Beneficial Ownership of the Company’s securities by any
    Person results solely from a reduction in the aggregate number of outstanding shares entitled to vote generally in the election of
    directors, or (2) such acquisition was approved in advance by the Continuing Directors (as defined below) and such acquisition would
    not constitute a Change in Control under part (c) of this definition;

 

    	 	 	 

     

    

 

	 	(b)	Change
    in Board of Directors. Individuals who, as of the date hereof, constitute the Board, and
    any new director whose election by the Board or nomination for election by the Company’s shareholders was approved by a vote
    of at least two thirds of the directors then still in office who were directors on the date hereof or whose election or nomination
    for election was previously so approved (collectively, the “Continuing Directors”), cease for any reason to constitute
    at least a majority of the members of the Board;

  

	 	(c)	Corporate
    Transactions. The effective date of a merger, share exchange, asset acquisition, share purchase,
    reorganization or similar business combination, involving the Company and one or more businesses (a “Business Combination”),
    in each case, unless, following such Business Combination: (1) all or substantially all of the individuals and entities who were
    the Beneficial Owners of securities entitled to vote generally in the election of directors immediately prior to such Business Combination
    beneficially own, directly or indirectly, more than 51% of the combined voting power of the then outstanding securities of the Company
    entitled to vote generally in the election of directors resulting from such Business Combination (including, without limitation,
    a company which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either
    directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior to such
    Business Combination, of the securities entitled to vote generally in the election of directors; (2) other than an affiliate of CHW
    Acquisition Sponsor LLC, no Person (excluding any company resulting from such Business Combination) is the Beneficial Owner, directly
    or indirectly, of 15% or more of the combined voting power of the then outstanding securities entitled to vote generally in the election
    of directors of the surviving company except to the extent that such ownership existed prior to the Business Combination; and (3)
    at least a majority of the Board resulting from such Business Combination were Continuing Directors at the time of the execution
    of the initial agreement, or of the action of the Board, providing for such Business Combination;
	 	 	 
	 	(d)	Liquidation.
    The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement or series of agreements
    for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring the Company’s
    current receivables or escrows due (or, if such approval is not required, the decision by the Board to proceed with such a liquidation,
    sale, or disposition in one transaction or a series of related transactions); or

  

	 	(e)	Other
    Events. There occurs any other event of a nature that would be required to be reported in
    response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated
    under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.

  

	2.5	“Corporate
    Status” describes the status of a person who is or was a director, officer, trustee, general partner, manager, managing
    member, fiduciary, employee or agent of the Company or of any other Enterprise (as defined below) which such person is or was serving
    at the request of the Company.

  

	2.6	“Disinterested
    Director” shall mean a director of the Company who is not and was not a party to the Proceeding (as defined below) in respect
    of which indemnification is sought by Indemnitee.

 

    	 	 	 

     

    

 

	2.7	“Enterprise”
    shall mean the Company and any other company, corporation, constituent company or corporation (including any constituent of a constituent)
    absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited liability
    company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the
    request of the Company as a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent.

  

	2.8	“Exchange
    Act” shall mean the United States Securities Exchange Act of 1934, as amended.
	 	 
	2.9	“Expenses”
    shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever, including, without limitation, all
    reasonable attorneys’ fees and costs, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses,
    fees of private investigators and professional advisors, duplicating costs, printing and binding costs, telephone charges, postage,
    delivery service fees, fax transmission charges, secretarial services and all other disbursements, obligations or expenses in connection
    with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, settlement or
    appeal of, or otherwise participating in, a Proceeding (as defined below), including reasonable compensation for time spent by Indemnitee
    for which he or she is not otherwise compensated by the Company or any third party. Expenses also shall include Expenses incurred
    in connection with any appeal resulting from any Proceeding (as defined below), including without limitation the principal, premium,
    security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent. Expenses, however,
    shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

 

 

	2.10	“Indemnity
    Obligations” shall mean all obligations of the Company to Indemnitee under this Agreement, including, without limitation,
    the Company’s obligations to provide indemnification to Indemnitee and advance Expenses to Indemnitee under this Agreement.

 

 

	2.11	“Independent
    Counsel” shall mean a law firm or a member of a law firm with significant experience in matters of corporate law and neither
    presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to
    either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar
    indemnification agreements); or (ii) any other party to the Proceeding (as defined below) giving rise to a claim for indemnification
    hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under
    the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company
    or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.

  

	2.12	References
    to “fines” shall include any excise tax assessed on Indemnitee with respect to any employee benefit plan; references
    to “serving at the request of the Company” shall include any service as a director, officer, employee, agent or
    fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with
    respect to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee
    reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall
    be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this
    Agreement.

 

    	 	 	 

     

    

 

	2.13	The term
    “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on the
    date hereof; provided, however, that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries (as defined
    below) of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of
    any company or corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions
    as their ownership of share of the Company; and (iv) any trustee or other fiduciary holding securities under an employee benefit
    plan of the Company or of a Subsidiary (as defined below) of the Company or of a company or corporation owned directly or indirectly
    by the shareholders of the Company in substantially the same proportions as their ownership of share of the Company.

  

	2.14	The term
    “Proceeding” shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate
    dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding,
    whether brought in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims),
    criminal, administrative, or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or
    otherwise by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action (or failure
    to act) taken by him or of any action (or failure to act) on his part while acting as a director or officer of the Company, or by
    reason of the fact that he is or was serving at the request of the Company as a director, officer, trustee, general partner, manager,
    managing member, fiduciary, employee or agent of any other Enterprise, in each case whether or not serving in such capacity at the
    time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under
    this Agreement.

  

	2.15	The term
    “Subsidiary,” with respect to any Person, shall mean any company, corporation, limited liability company, partnership,
    joint venture, trust or other entity of which a majority of the voting power of the voting equity securities or equity interest is
    owned, directly or indirectly, by that Person.

  

	3	INDEMNITY
    IN THIRD-PARTY PROCEEDINGS

To the fullest extent permitted by applicable law and the
Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section 3 if
Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding,
other than a Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate
Status. Pursuant to this Section 3, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities,
fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection
with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred by
Indemnitee or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith
and in a manner he reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding,
had no reasonable cause to believe that his conduct was unlawful; provided, in no event shall Indemnitee be entitled to be indemnified,
held harmless or advanced any amounts hereunder in respect of any Expenses, judgments, liabilities, fines, penalties and amounts paid
in settlement (if any) that Indemnitee may incur by reason of his or her own actual fraud or intentional misconduct. Indemnitee shall
not be found to have committed actual fraud or intentional misconduct for any purpose of this Agreement unless or until a court of competent
jurisdiction shall have made a finding to that effect.

 

    	 	 	 

     

    

 

	4	INDEMNITY
    IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY

To the fullest extent permitted by applicable law and the
Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section 4 if
Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding
by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate Status. Pursuant to this
Section 4, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him
or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a
manner he reasonably believed to be in or not opposed to the best interests of the Company. No indemnification, hold harmless or exoneration
for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally
adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that any court in which the
Proceeding was brought or the Cayman Court shall determine upon application that, despite the adjudication of liability but in view of
all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless or to exoneration.

 

	5	INDEMNIFICATION
    FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL

Notwithstanding any other provisions of this Agreement except
for Section 27, to the extent that Indemnitee was or is, by reason of Indemnitee’s Corporate Status, a party to (or a participant
in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or
in part, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate
Indemnitee against all Expenses actually and reasonably incurred by him in connection therewith. If Indemnitee is not wholly successful
in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such
Proceeding, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate
Indemnitee against all Expenses actually and reasonably incurred by him or on his behalf in connection with each successfully resolved
claim, issue or matter. If Indemnitee is not wholly successful in such Proceeding, the Company also shall, to the fullest extent permitted
by applicable law and the Articles, indemnify, hold harmless and exonerate Indemnitee against all Expenses reasonably incurred in connection
with a claim, issue or matter related to any claim, issue, or matter on which Indemnitee was successful. For purposes of this Section
5 and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice,
shall be deemed to be a successful result as to such claim, issue or matter.

 

	6	INDEMNIFICATION
    FOR EXPENSES OF A WITNESS

Notwithstanding any other provision of this Agreement except
for Section 27, to the extent that Indemnitee is, by reason of his Corporate Status, a witness or deponent in any Proceeding to which
Indemnitee is not a party or threatened to be made a party, he shall, to the fullest extent permitted by applicable law and the Articles,
be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or on his behalf in connection
therewith.

 

    	 	 	 

     

    

 

	7	ADDITIONAL
    INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS

 

	7.1	Notwithstanding
    any limitation in Sections 3, 4, or 5, except for Section 27, the Company shall, to the fullest extent permitted by applicable law
    and the Articles, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party
    to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses,
    judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable
    in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably
    incurred by Indemnitee in connection with the Proceeding. No indemnification, hold harmless or exoneration rights shall be available
    under this Section 7.1 on account of Indemnitee’s conduct which constitutes a breach of Indemnitee’s duty of loyalty
    to the Company or its shareholders or is an act or omission not in good faith or which involves intentional misconduct or a knowing
    violation of the law.

  

	7.2	Notwithstanding
    any limitation in Sections 3, 4, 5 or 7.1, except for Section 27, the Company shall, to the fullest extent permitted by applicable
    law and the Articles, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party
    to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses,
    judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable
    in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably
    incurred by Indemnitee in connection with the Proceeding.

  

	8	CONTRIBUTION
    IN THE EVENT OF JOINT LIABILITY

  

	8.1	To the
    fullest extent permitted by applicable law and the Articles, if the indemnification, hold harmless and/or exoneration rights provided
    for in this Agreement are unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying,
    holding harmless or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for
    judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding
    without requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution
    it may have at any time against Indemnitee.

  

	 	8.2	The Company
    shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined
    in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

  

	8.3	The Company
    hereby agrees to fully indemnify, hold harmless and exonerate Indemnitee from any claims for contribution which may be brought by
    officers, directors or employees of the Company other than Indemnitee who may be jointly liable with Indemnitee.

  

	 	9	EXCLUSIONS

Notwithstanding
any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification, advance expenses,
hold harmless or exoneration payment in connection with any claim made against Indemnitee:

 

	 	(a)	for which
    payment has actually been received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement provision,
    except with respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other indemnity
    or advancement provision or otherwise;

  

	 	(b)	for an
    accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the
    meaning of Section 16(b) of the Exchange Act or similar provisions of state statutory law or common law; or

 

    	 	 	 

     

    

 

	 	(c)	except
    as otherwise provided in Sections 14.5 and 14.6 hereof, prior to a Change in Control, in connection with any Proceeding (or any part
    of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against
    the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part
    of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification, hold harmless or exoneration payment,
    in its sole discretion, pursuant to the powers vested in the Company under applicable law. Indemnitee shall seek payments or advances
    from the Company only to the extent that such payments or advances are unavailable from any insurance policy of the Company covering
    Indemnitee.

  

	10	ADVANCES
    OF EXPENSES; DEFENSE OF CLAIM

 

	10.1	Notwithstanding
    any provision of this Agreement to the contrary except for Section 27, and to the fullest extent not prohibited by applicable law
    or the Articles, the Company shall pay the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be incurred by
    Indemnitee within three months) in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement
    or statements requesting such advances from time to time, prior to the final disposition of any Proceeding. Advances shall, to the
    fullest extent permitted by applicable law, be unsecured and interest free. Advances shall, to the fullest extent permitted by applicable
    law and the Articles, be made without regard to Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s
    ultimate entitlement to be indemnified, held harmless or exonerated under the other provisions of this Agreement. Advances shall
    include any and all reasonable Expenses incurred pursuing a Proceeding to enforce this right of advancement, including Expenses incurred
    preparing and forwarding statements to the Company to support the advances claimed. To the fullest extent required by applicable
    law and the Articles, such payments of Expenses in advance of the final disposition of the Proceeding shall be made only upon the
    Company’s receipt of an undertaking, by or on behalf of Indemnitee, to repay the advanced amounts to the extent that it is
    ultimately determined that Indemnitee is not entitled to be indemnified by the Company under the provisions of this Agreement, the
    Articles, applicable law or otherwise. If it shall be determined by a final judgement or other final adjudication that Indemnitee
    was not so entitled to indemnification, any advanced amount shall be returned to the Company (without interest) by the Indemnitee.
    This Section 10.1 shall not apply to any claim made by Indemnitee for which an indemnification, hold harmless or exoneration payment
    is excluded pursuant to Section 9.

  

	10.2	The Company
    will be entitled to participate in the Proceeding at its own expense.

  

	10.3	The Company
    shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or
    limitation on Indemnitee without Indemnitee’s prior written consent.

  

	11	PROCEDURE
    FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION

  

	11.1	Indemnitee
    agrees to notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information
    or other document relating to any Proceeding or matter which may be subject to indemnification, hold harmless or exoneration rights,
    or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of
    any obligation which it may have to Indemnitee under this Agreement, or otherwise.

 

    	 	 	 

     

    

 

	11.2	Indemnitee
    may deliver to the Company a written application to indemnify, hold harmless or exonerate Indemnitee in accordance with this Agreement.
    Such application(s) may be delivered from time to time and at such time(s) as Indemnitee deems appropriate in his or her sole discretion.
    Following such a written application for indemnification by Indemnitee, Indemnitee’s entitlement to indemnification shall be
    determined according to Section 12.1 of this Agreement.

  

	12	PROCEDURE
    UPON APPLICATION FOR INDEMNIFICATION

  

	12.1	A determination,
    if required by applicable law and the Articles, with respect to Indemnitee’s entitlement to indemnification shall be made in
    the specific case by one of the following methods: (i) if no Change in Control has occurred, (x) by a majority vote of the Disinterested
    Directors, even though less than a quorum of the Board, (y) by a committee of Disinterested Directors, even though less than a quorum
    of the Board, or (z) if there are no Disinterested Directors, or if such Disinterested Directors so direct, by Independent Counsel
    in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (ii) if a Change in Control has occurred,
    by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee. The Company will promptly
    advise Indemnitee in writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including
    a description of any reason or basis for which indemnification has been denied. If it is so determined that Indemnitee is entitled
    to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall reasonably
    cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification,
    including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not
    privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such
    determination. Any costs or Expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so
    cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination
    as to Indemnitee’s entitlement to indemnification) and the Company hereby agrees to indemnify and to hold Indemnitee harmless
    therefrom.

 

    	 	 	 

     

    

 

	12.2	In the
    event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12.1 hereof, the
    Independent Counsel shall be selected as provided in this Section 12.2. The Independent Counsel shall be selected by Indemnitee (unless
    Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising
    it of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements
    of “Independent Counsel” as defined in Section 2 of this Agreement. If the Independent Counsel is selected by the Board,
    the Company shall give written notice to Indemnitee advising him of the identity of the Independent Counsel so selected and certifying
    that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this
    Agreement. In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of
    selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection;
    provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet
    the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set forth
    with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as
    Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as
    Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection
    is without merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant to
    Section 11.2 hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition
    the Cayman Court for resolution of any objection which shall have been made by the Company or Indemnitee to the other’s selection
    of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the Cayman Court, and the person
    with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 12.1
    hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14.1 of this Agreement, Independent
    Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional
    conduct then prevailing).

  

	12.3	The Company
    agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent Counsel
    against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant
    hereto.

  

	13	PRESUMPTIONS
    AND EFFECT OF CERTAIN PROCEEDINGS

  

	13.1	In making
    a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination
    shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification
    in accordance with Section 11.2 of this Agreement, and the Company shall have the burden of proof to overcome that presumption in
    connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure
    of the Company (including by its Disinterested Directors or Independent Counsel) to have made a determination prior to the commencement
    of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable
    standard of conduct, nor an actual determination by the Company (including by its Disinterested Directors or Independent Counsel)
    that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee
    has not met the applicable standard of conduct.

 

    	 	 	 

     

    

 

	13.2	If the
    person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to
    indemnification shall not have made a determination within thirty (30) days after receipt by the Company of the request therefor,
    the requisite determination of entitlement to indemnification shall, to the fullest extent permitted by applicable law and the Articles,
    be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of
    a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection
    with the request for indemnification, or (ii) a final judicial determination that any or all such indemnification is expressly prohibited
    under applicable law; provided, however, that such 30-day period may be extended for a reasonable time, not to exceed an additional
    fifteen (15) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good
    faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto.

  

	13.3	The termination
    of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo
    contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the
    right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he
    reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that
    Indemnitee had reasonable cause to believe that his conduct was unlawful.

  

	13.4	For purposes
    of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based
    on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by
    the directors, managers, managing members, or officers of the Enterprise in the course of their duties, or on the advice of legal
    counsel for the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager, or managing
    member or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any director,
    trustee, general partner, manager or managing member by an independent certified public accountant or by an appraiser or other expert
    selected by the Enterprise, its Board, any committee of the Board or any director, trustee, general partner, manager or managing
    member. The provisions of this Section 13.4 shall not be deemed to be exclusive or to limit in any way the other circumstances in
    which Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement.

  

	13.5	The knowledge
    and/or actions, or failure to act, of any other director, officer, trustee, partner, manager, managing member, fiduciary, agent or
    employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this
    Agreement.

 

    	 	 	 

     

    

 

	14	REMEDIES
    OF INDEMNITEE

  

	14.1	In the
    event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification
    under this Agreement, (ii) advancement of Expenses, to the fullest extent permitted by applicable law and the Articles, is not timely
    made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant
    to Section 12.1 of this Agreement within thirty (30) days after receipt by the Company of the request for indemnification, (iv) payment
    of indemnification is not made pursuant to Sections 5, 6, 7 or the last sentence of Section 12.1 of this Agreement within ten (10)
    days after receipt by the Company of a written request therefor, (v) a contribution payment is not made in a timely manner pursuant
    to Section 8 of this Agreement, (vi) payment of indemnification pursuant to Section 3 or 4 of this Agreement is not made in accordance
    with this Agreement within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vii)
    payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made within ten
    (10) days after receipt by the Company of a written request therefor, Indemnitee shall be entitled to an adjudication by the Cayman
    Court to such indemnification, hold harmless, exoneration, contribution or advancement rights. Alternatively, Indemnitee, at his
    option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules and
    Mediation Procedures of the American Arbitration Association. Except as set forth herein, the provisions of Cayman Islands law (without
    regard to its conflict of laws rules) shall apply to any such arbitration. The Company shall not oppose Indemnitee’s right
    to seek any such adjudication or award in arbitration.

  

	14.2	In the
    event that a determination shall have been made pursuant to Section 12.1 of this Agreement that Indemnitee is not entitled to indemnification,
    any judicial proceeding or arbitration commenced pursuant to this Section 14 shall be conducted in all respects as a de novo trial,
    or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding
    or arbitration commenced pursuant to this Section 14, Indemnitee shall be presumed to be entitled to be indemnified, held harmless,
    exonerated to receive advances of Expenses under this Agreement and the Company shall have the burden of proving Indemnitee is not
    entitled to be indemnified, held harmless, exonerated and to receive advances of Expenses, as the case may be, and the Company may
    not refer to or introduce into evidence any determination pursuant to Section 12.1 of this Agreement adverse to Indemnitee for any
    purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section 14, Indemnitee shall not be required
    to reimburse the Company for any advances pursuant to Section 10 until a final determination is made with respect to Indemnitee’s
    entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

  

	14.3	If a determination
    shall have been made pursuant to Section 12.1 of this Agreement that Indemnitee is entitled to indemnification, the Company shall
    be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 14, absent (i) a misstatement
    by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially
    misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.

  

	14.4	The Company
    shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures
    and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such
    arbitrator that the Company is bound by all the provisions of this Agreement.

 

    	 	 	 

     

    

 

	14.5	The Company
    shall indemnify and hold harmless Indemnitee to the fullest extent permitted by applicable law and the Articles against all Expenses
    and, if requested by Indemnitee, shall (within ten (10) days after the Company’s receipt of such written request) pay to Indemnitee,
    to the fullest extent permitted by applicable law and the Articles, such Expenses which are incurred by Indemnitee in connection
    with any judicial proceeding or arbitration brought by Indemnitee (i) to enforce his rights under, or to recover damages for breach
    of, this Agreement or any other indemnification, hold harmless, exoneration, advancement or contribution agreement or provision of
    the Articles now or hereafter in effect; or (ii) for recovery or advances under any insurance policy maintained by any person for
    the benefit of Indemnitee, regardless of the outcome and whether Indemnitee ultimately is determined to be entitled to such indemnification,
    hold harmless or exoneration right, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding
    or arbitration was not brought by Indemnitee in good faith).

  

	14.6	Interest
    shall be paid by the Company to Indemnitee at the legal rate under New York law for amounts which the Company indemnifies, holds
    harmless or exonerates, or is obliged to indemnify, hold harmless or exonerate for the period commencing with the date on which Indemnitee
    requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending
    with the date on which such payment is made to Indemnitee by the Company.

  

	15	SECURITY

Notwithstanding anything herein to the contrary except for
Section 27, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time to time provide
security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other
collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of Indemnitee.

 

	16	NON-EXCLUSIVITY;
    SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION

  

	16.1	The rights
    of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time
    be entitled under applicable law, the Articles, any agreement, a vote of shareholders or a resolution of directors, or otherwise.
    No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under
    this Agreement in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) arising
    out of, or related to, any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration
    or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, permits greater indemnification,
    hold harmless or exoneration rights or advancement of Expenses than would be afforded currently under the Articles or this Agreement,
    then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be amended to require that
    the Company indemnifies Indemnitee to the fullest extent permitted by law. No right or remedy herein conferred is intended to be
    exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right
    and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right
    or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

 

    	 	 	 

     

    

 

	16.2	The Companies
    Law (2020 Revision) of the Cayman Islands and the Articles permit the Company to purchase and maintain insurance or furnish similar
    protection or make other arrangements including, but not limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification
    Arrangements”) on behalf of Indemnitee against any liability asserted against him or incurred by or on behalf of him or
    in such capacity as a director, officer, employee or agent of the Company, or arising out of his status as such, whether or not the
    Company would have the power to indemnify him against such liability under the provisions of this Agreement or under the Companies
    Law (2020 Revision) of the Cayman Islands, as it may then be in effect. The purchase, establishment, and maintenance of any such
    Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under
    this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Company and Indemnitee
    shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such
    Indemnification Arrangement.

  

	16.3	To the
    extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, trustees,
    partners, managers, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise which such person
    serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their terms
    to the maximum extent of the coverage available for any such director, officer, trustee, partner, manager, managing member, fiduciary,
    employee or agent under such policy or policies. If, at the time the Company receives notice from any source of a Proceeding as to
    which Indemnitee is a party or a participant (as a witness, deponent or otherwise), the Company has director and officer liability
    insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set
    forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay,
    on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.

  

	16.4	In the
    event of any payment under this Agreement, the Company, to the fullest extent permitted by applicable law and the Articles, shall
    be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required
    and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company
    to bring suit to enforce such rights. No such payment by the Company shall be deemed to relive any insurer of its obligations.

  

	16.5	The Company’s
    obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the request
    of the Company as a director, officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any other Enterprise
    shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless or exoneration payments or advancement
    of expenses from such Enterprise. Notwithstanding any other provision of this Agreement to the contrary except for Section 27, (i)
    Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration,
    advancement, contribution or insurance coverage among multiple parties possessing such duties to Indemnitee prior to the Company’s
    satisfaction and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations
    under this Agreement without regard to whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, hold
    harmless, exoneration, contribution or insurance coverage rights against any person or entity other than the Company.

 

    	 	 	 

     

    

 

	16.6	The Company
    hereby acknowledges that Indemnitee may have certain rights to indemnification, advancement of Expenses and/or insurance provided
    by one or more Persons with whom or which Indemnitee may be associated. The Company hereby acknowledges and agrees that (i) the Company
    shall be the indemnitor of first resort with respect to any Proceeding, Expense, liability or matter that is the subject of the Indemnity
    Obligations, (ii) the Company shall be primarily liable for all Indemnity Obligations and any indemnification afforded to Indemnitee
    in respect of any Proceeding, Expense, liability or matter that is the subject of Indemnity Obligations, whether created by law,
    organizational or constituent documents, contract (including, without limitation, this Agreement) or otherwise, (iii) any obligation
    of any other Persons with whom or which Indemnitee may be associated to indemnify Indemnitee and/or advance Expenses to Indemnitee
    in respect of any proceeding shall be secondary to the obligations of the Company hereunder, (iv) the Company shall be required to
    indemnify Indemnitee and advance Expenses to Indemnitee hereunder to the fullest extent provided herein without regard to any rights
    Indemnitee may have against any other Person with whom or which Indemnitee may be associated or insurer of any such Person and (v)
    the Company irrevocably waives, relinquishes and releases any other Person with whom or which Indemnitee may be associated from any
    claim of contribution, subrogation or any other recovery of any kind in respect of amounts paid by the Company hereunder. In the
    event that any other Person with whom or which Indemnitee may be associated or their insurers advances or extinguishes any liability
    or loss which is the subject of any Indemnity Obligation owed by the Company or payable under any insurance policy provided under
    this Agreement, the payor shall have a right of subrogation against the Company or its insurer or insurers for all amounts so paid
    which would otherwise be payable by the Company or its insurer or insurers under this Agreement. In no event will payment of an Indemnity
    Obligation of the Company under this Agreement by any other Person with whom or which Indemnitee may be associated or their insurers,
    affect the obligations of the Company hereunder or shift primary liability for any Indemnity Obligation to any other Person with
    whom or which Indemnitee may be associated. Any indemnification and/or insurance or advancement of Expenses provided by any other
    Person with whom or which Indemnitee may be associated, with respect to any liability arising as a result of Indemnitee’s Corporate
    Status or capacity as an officer or director of any Person, is specifically in excess of any Indemnity Obligation of the Company
    or valid and any collectible insurance (including, without limitation, any malpractice insurance or professional errors and omissions
    insurance) provided by the Company under this Agreement, and any obligation to provide indemnification and/or insurance or advance
    Expenses provided by any other Person with whom or which Indemnitee may be associated shall be reduced by any amount that Indemnitee
    collects from the Company as an indemnification payment or advancement of Expenses pursuant to this Agreement.

  

	17	DURATION
    OF AGREEMENT

All agreements and obligations of the Company contained
herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director, officer, trustee,
partner, manager, managing member, fiduciary, employee or agent of any other company, corporation, partnership, joint venture, trust,
employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so long
as Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by Indemnitee
pursuant to Section 14 of this Agreement) by reason of his Corporate Status, whether or not he is acting in any such capacity at the
time any liability or expense is incurred for which indemnification or advancement can be provided under this Agreement.

 

    	 	 	 

     

    

 

	18	SEVERABILITY

If any provision or provisions of this Agreement shall be
held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining
provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing
any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any
way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by applicable law (and the Articles);
(b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum
effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without
limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal
or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested
thereby.

 

	19	ENFORCEMENT
    AND BINDING EFFECT

  

	19.1	The Company
    expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to
    induce Indemnitee to serve as a director, officer or key employee of the Company, and the Company acknowledges that Indemnitee is
    relying upon this Agreement in serving as a director, officer or key employee of the Company.

 

 

	19.2	Without
    limiting any of the rights of Indemnitee under the Articles as they may be amended from time to time, this Agreement constitutes
    the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and
    understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.

  

	19.3	The indemnification,
    hold harmless, exoneration and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding
    upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor
    by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company), shall
    continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or a director, officer, trustee,
    general partner, manager, managing member, fiduciary, employee or agent of any other Enterprise at the Company’s request, and
    shall inure to the benefit of Indemnitee and his or her spouse, assigns, heirs, devisees, executors and administrators and other
    legal representatives.

  

	19.4	The Company
    shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially
    all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory
    to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company
    would be required to perform if no such succession had taken place.

 

    	 	 	 

     

    

 

	19.5	The Company
    and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable
    and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto
    agree that Indemnitee may, to the fullest extent permitted by applicable law and the Articles, enforce this Agreement by seeking,
    among other things, injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable
    harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining
    any other relief to which he may be entitled. The Company and Indemnitee further agree that Indemnitee shall to the fullest extent
    permitted by applicable law (and the Articles) be entitled to such specific performance and injunctive relief, including temporary
    restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking
    in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee
    by a Court of competent jurisdiction and the Company hereby waives any such requirement of such a bond or undertaking to the fullest
    extent permitted by applicable law and the Articles.

  

	20	MODIFICATION
    AND WAIVER

No supplement, modification or amendment of this Agreement
shall be binding unless executed in writing by the Company and Indemnitee. No waiver of any of the provisions of this Agreement shall
be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.

 

	21	NOTICES

All notices, requests, demands and other communications
under this Agreement shall be in writing and shall be deemed to have been duly given (i) if delivered by hand and receipted for by the
party to whom said notice or other communication shall have been directed, or (ii) mailed by certified or registered mail with postage
prepaid, on the third (3rd) business day after the date on which it is so mailed:

 

	 	(a)	If to
    Indemnitee, at the address indicated on the signature page of this Agreement or such other address as Indemnitee shall provide in
    writing to the Company.

  

	 	(b)	If to
    the Company, to:

CHW
Acquisition Corporation

2 Manhattanville Road, Suite 403

 

Purchase, NY 10577

Attn: Jonah Raskas

 

With a copy, which shall not constitute notice, to:

 

Reed Smith LLP 

599 Lexington Avenue 

New York, NY 10022 

Attn: Ari Edelman, Esq.

 

or to any other address as may have been furnished to Indemnitee
in writing by the Company.

 

    	 	 	 

     

    

 

	22	APPLICABLE
    LAW AND CONSENT TO JURISDICTION

This Agreement and the legal relations among the parties
shall be governed by, and construed and enforced in accordance with, the laws of the State of New York. Except with respect to any arbitration
commenced by Indemnitee pursuant to Section 14.1 of this Agreement, to the fullest extent permitted by law the Company and Indemnitee
hereby irrevocably and unconditionally: (a) agree that any action or proceeding arising out of or in connection with this Agreement shall
be brought only in the Courts of the State of New York and not in any other state or federal court in the United States of America or
any court in any other country; (b) consent to submit to the exclusive jurisdiction of the Courts of the State of New York for purposes
of any action or proceeding arising out of or in connection with this Agreement; (c) waive any objection to the laying of venue of any
such action or proceeding in the Courts of the State of New York; and (d) waive, and agree not to plead or to make, any claim that any
such action or proceeding brought in the Courts of the State of New York has been brought in an improper or inconvenient forum, or is
subject (in whole or in part) to a jury trial. To the fullest extent permitted by law, the parties hereby agree that the mailing of process
and other papers in connection with any such action or proceeding in the manner provided by Section 21 or such other manner as may be
permitted by law, shall be valid and sufficient service thereof.

 

	23	IDENTICAL
    COUNTERPARTS

This Agreement may be executed in one or more counterparts,
each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement.
Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of
this Agreement.

 

	24	MISCELLANEOUS

Use of the masculine pronoun shall be deemed to include
usage of the feminine pronoun where appropriate. The headings of the paragraphs of this Agreement are inserted for convenience only and
shall not be deemed to constitute part of this Agreement or to affect the construction thereof.

 

	25	PERIOD
    OF LIMITATIONS

No legal action shall be brought and no cause of action
shall be asserted by or in the right of the Company against Indemnitee, Indemnitee’s spouse, heirs, executors or personal or legal
representatives after the expiration of two years from the date of accrual of such cause of action, and any claim or cause of action
of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such two-year
period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action such shorter
period shall govern.

 

	26	ADDITIONAL
    ACTS

If for the validation of any of the provisions in this Agreement
any act, resolution, approval or other procedure is required, to the fullest extent permitted by law, the Company undertakes to cause
such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfil its obligations
under this Agreement.

 

	27	WAIVER
    OF CLAIMS TO TRUST ACCOUNT

Indemnitee hereby agrees that it does not have any right,
title, interest or claim of any kind (each, a “Claim”) in or to any monies in the trust account established in connection
with the Company’s initial public offering for the benefit of the Company and holders of shares issued in such offering, and hereby
waives any Claim it may have in the future as a result of, or arising out of, any services provided to the Company and will not seek
recourse against such trust account for any reason whatsoever. Accordingly, Indemnitee acknowledges and agrees that any indemnification
provided hereto will only be able to be satisfied by the Company if (i) the Company has sufficient funds outside of the Trust Account
to satisfy its obligations hereunder or (ii) the Company consummated a Business Combination.

 

    	 	 	 

     

    

 

	28.	MAINTENANCE
    OF INSURANCE

The Company shall use commercially reasonable efforts to
obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under this Agreement,
one or more policies of insurance with reputable insurance companies to provide the officers/directors of the Company with coverage for
losses from wrongful acts and omissions and to ensure the Company’s performance of its indemnification obligations under this Agreement.
The Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage
available for any such director or officer under such policy or policies. In all such insurance policies, the Indemnitee shall be named
as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured
of the Company’s directors and officers.

 

	29.	INTERPRETATION

In this Agreement:

 

	 	(a)	words
    importing the singular number include the plural number and vice versa; words importing the masculine gender include the feminine
    gender;
	 	 	 
	 	(b)	“written”
    and “in writing” include all modes of representing or reproducing words in visible form, including in the form of an
    Electronic Record;
	 	 	 
	 	(c)	“shall”
    shall be construed as imperative and “may” shall be construed as permissive;
	 	 	 
	 	(d)	references
    to provisions of any law or regulation shall be construed as references to those provisions as amended, modified, re-enacted or replaced;
	 	 	 
	 	(e)	any phrase
    introduced by the terms “including”, “include”, “in particular” or any similar expression shall
    be construed as illustrative and shall not limit the sense of the words preceding those terms;
	 	 	 
	 	(f)	the term
    “and/or” is used herein to mean both “and” as well as “or. “ The use of “and/or”
    in certain contexts in no respects qualifies or modifies the use of the terms “and” or “or” in others. The
    term “or” shall not be interpreted to be exclusive and the term “and” shall not be interpreted to require
    the conjunctive (in each case, unless the context otherwise requires);
	 	 	 
	 	(g)	headings
    are inserted for reference only and shall be ignored in construing this Agreement;
	 	 	 
	 	(h)	any requirements
    as to delivery under this Agreement include delivery in the form of an electronic record (as defined in the Electronic Transactions
    Law (2003));
	 	 	 
	 	(i)	any requirements
    as to execution or signature under this Agreement including the execution of this Agreement itself can be satisfied in the form of
    an electronic signature (as defined in the Electronic Transactions Law (2003 Revision));
	 	 	 
	 	(j)	sections
    8 and 19(3) of the Electronic Transactions Law (2003 Revision) shall not apply

 

[SIGNATURE PAGE FOLLOWS] 

 

    	 	 	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed on the day and year first above written.

 

	 	CHW
    ACQUISITION CORPORATION
	 	 	 
	 	By:	 
	 	 	Name:
    Jonah Raskas
	 	 	Title:
    Co-Chief Executive Officer
	 	 	 
	 	INDEMNITEE

  

	 	By:	 
	 	 	Name:

 

 [Signature Page to Indemnity Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]